什么影响药监质量? 从定性比较分析的洞察力
Yadong Wang1, Yue Chen1, Xingjuan Xu1
1Anhui Medical University, School of Pharmacy, Hefei, Anhui Province, China.
Pharmacology research & perspectives
|May 9, 2025
概括
在中国,高质量的药监监测需要了解复杂的影响因素. 该研究确定了提高药物安全的三个关键途径,其中专注和合格的药监人员至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 监管科学 监管科学
背景情况:
- 30多年来,中国已经推进了药物监管 (PV),但质量驱动因素仍然不清楚.
- 确保药物安全是关键的公共卫生目标.
- 了解影响光伏质量的因素对于改进至关重要.
研究的目的:
- 调查影响中国药监质量的互动因素.
- 确定实现高质量的药物监督实践的途径.
- 为加强药物安全系统提供见解.
主要方法:
- 在药监督检查报告上使用了清晰的定性比较分析 (csQCA).
- 采用了技术-组织-环境 (TOE) 理论框架.
- 进行了定量单变量需求和配置分析.
主要成果:
- 确定了三个不同的途径,有助于高质量的药物监督.
- "专注和合格的药监人员 (DQPPV) "是所有确定的途径的核心.
- 分析阐明了药监质量先例之间的相互作用.
结论:
- DQPPV是高质量的药物监测的关键因素,需要进一步调查.
- 这些发现使得有针对性的措施能够提高光伏系统的功能和质量.
- 结果支持营销许可证持有人 (MAHs) 改进他们的光伏努力.
相关概念视频
Pharmacovigilance
744
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
744
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
Factors Influencing Drug Absorption: Pharmaceutical Parameters
101
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
101
Analysis of Population Pharmacokinetic Data
198
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
198
Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Bioequivalence: Overview
880
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
880


